Osmosis Investment Management UK Ltd Takes $1.01 Million Position in Markel Group Inc. $MKL

Osmosis Investment Management UK Ltd purchased a new stake in Markel Group Inc. (NYSE:MKL) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 517 shares of the insurance provider’s stock, valued at approximately $1,010,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in MKL. BlackRock Inc. acquired a new position in Markel Group during the 2nd quarter valued at about $1,362,880,000. Davis Selected Advisers grew its position in shares of Markel Group by 11.1% during the 4th quarter. Davis Selected Advisers now owns 415,160 shares of the insurance provider’s stock worth $892,496,000 after buying an additional 41,632 shares during the period. Select Equity Group L.P. grew its position in shares of Markel Group by 75.9% during the 2nd quarter. Select Equity Group L.P. now owns 336,369 shares of the insurance provider’s stock worth $671,850,000 after buying an additional 145,146 shares during the period. State Street Corp raised its stake in shares of Markel Group by 2.1% during the third quarter. State Street Corp now owns 304,400 shares of the insurance provider’s stock worth $581,818,000 after buying an additional 6,160 shares during the last quarter. Finally, Van Lanschot Kempen Investment Management N.V. raised its stake in shares of Markel Group by 13.0% during the fourth quarter. Van Lanschot Kempen Investment Management N.V. now owns 204,861 shares of the insurance provider’s stock worth $440,379,000 after buying an additional 23,631 shares during the last quarter. 77.12% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have commented on MKL shares. Wall Street Zen raised shares of Markel Group from a “sell” rating to a “hold” rating in a report on Saturday, August 1st. Truist Financial reduced their price target on Markel Group from $2,100.00 to $1,950.00 and set a “hold” rating on the stock in a research report on Thursday, April 30th. Wolfe Research began coverage on Markel Group in a research note on Wednesday, July 1st. They set an “underperform” rating for the company. Finally, Weiss Ratings upgraded Markel Group from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, August 17th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $2,025.00.

Markel Group Trading Up 1.2%

NYSE:MKL opened at $1,817.76 on Tuesday. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.63 and a quick ratio of 0.63. The business’s 50-day simple moving average is $1,907.04 and its 200-day simple moving average is $1,919.36. Markel Group Inc. has a fifty-two week low of $1,719.41 and a fifty-two week high of $2,207.59. The stock has a market capitalization of $22.52 billion, a PE ratio of 10.00 and a beta of 0.66.

Markel Group Profile

Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.

In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.